The cross‐above trial carried out by Palevitch et al involved fifty seven individuals with migraine diagnosed by medical evaluation (diagnostic standards not specified) (Palevitch 1997). Members as youthful as 9 decades aged (age variety 9 to sixty five decades) were being provided Even with migraine having distinctive qualities in youthful men a